[TREATMENTS FOR PRESBYOPIA].


Journal

Harefuah
ISSN: 0017-7768
Titre abrégé: Harefuah
Pays: Israel
ID NLM: 0034351

Informations de publication

Date de publication:
Jul 2022
Historique:
entrez: 14 7 2022
pubmed: 15 7 2022
medline: 16 7 2022
Statut: ppublish

Résumé

Presbyopia is the physiological, gradual, progressive loss of the ability to see clearly at near point which affects people as they age. It is primarily caused by the thickening and stiffening of the lens leading to an inability to adjust its shape to become convex enough to induce adequate plus power to see at short distances. Symptoms usually begin affecting individuals around 40 years of age, the most common being discomfort in or around the eyes after prolonged near work, blur at distance after near work, and eventually progressing to near blur, often with a natural tendency to distance the object by holding it farther away to try to see it better. At a certain point near tasks become impossible and the patient will seek an external solution. Various therapies are available and being developed to treat presbyopia, which include glasses, contact lenses, intraocular lens implants, corneal laser procedures, intracorneal implants, scleral alterations and pharmacological ocular drops. Untreated presbyopia negatively affects quality of life as well as the world productivity since presbyopia progresses from approximately an age when people are still an active part of the workforce. As the population and life expectancy grow, so will the number of presbyopes. This article will discuss the various options available to treat presbyopia.

Identifiants

pubmed: 35833432

Types de publication

Journal Article Review

Langues

heb

Sous-ensembles de citation

IM

Pagination

448-453

Auteurs

Nir Erdinest (N)

Department of Ophthalmology, Hadassah-Hebrew University Medical Center.

Yair Morad (Y)

Department of Ophthalmology, Yitzhak Shamir Medical Center.

Naomi London (N)

Private clinic, Jerusalem, Israel.

Or Shmueli (O)

Department of Ophthalmology, Hadassah-Hebrew University Medical Center.

Itay Lavy (I)

Department of Ophthalmology, Hadassah-Hebrew University Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH